SINJARD-L 10/5 contains Empagliflozin 10 mg and Linagliptin 5 mg. It is a combination oral antidiabetic medicine used to improve blood glucose control in patients with type 2 diabetes mellitus.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Helps improve blood sugar control along with diet and exercise
-
Empagliflozin helps reduce blood glucose by increasing glucose removal through urine
-
Linagliptin helps increase insulin release and reduce excess glucose production
-
Used when single diabetes medicines are not sufficient for adequate blood glucose control
Dose:
-
Adults: Usually 1 tablet once daily or as directed by a physician
-
Can be taken with or without food
-
Maintain adequate fluid intake as advised by a healthcare professional
-
Dose depends on the patient’s condition, kidney function, and response to treatment
-
Follow the prescribed dose and duration as advised by a healthcare professional